Hosted on MSN20d
Infex Therapeutics secures £1 million for drug developmentALDERLEY PARK, Cheshire - Infex Therapeutics Holdings plc, a UK-based anti-infectives specialist, in partnership with Justus-Liebig-University Giessen (JLU) in Germany, has been awarded a £1 ...
ALDERLEY PARK, Cheshire, U.K. - Infex Therapeutics has entered into an exclusive license agreement with Venus Remedies Ltd, an Indian pharmaceutical company, to further develop and commercialize ...
Venus Remedies has entered into an exclusive license agreement with Infex Therapeutics, a UK-based anti-infectives specialist, for the clinical development of MET-X. This agreement authorizes Venus ...
Infex will receive licence fee payments upon signature and completion of near-term milestones and tiered double-digit royalty payments on net sales of MET-X/meropenem in India by Venus.
ALDERLEY PARK, Cheshire, U.K. - Infex Therapeutics has entered into an exclusive license agreement with Venus Remedies Ltd, an Indian pharmaceutical company, to further develop and commercialize MET-X ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results